Legend Biotech Corporation Aktie
WKN DE: A2P5AH / ISIN: US52490G1022
|
11.08.2025 14:02:51
|
Legend Biotech Corporation Q2 Loss Climbs
(RTTNews) - Legend Biotech Corporation (LEGN) revealed Loss for its second quarter of -$125.380 million
The company's bottom line came in at -$125.380 million, or -$0.34 per share. This compares with -$18.196 million, or -$0.05 per share, last year.
The company's revenue for the period rose 36.7% to $255.058 million from $186.523 million last year.
Legend Biotech Corporation earnings at a glance (GAAP) :
-Earnings: -$125.380 Mln. vs. -$18.196 Mln. last year. -EPS: -$0.34 vs. -$0.05 last year. -Revenue: $255.058 Mln vs. $186.523 Mln last year.
Excluding items, income was $10.091 million, or $0.03 per share, compared with a loss of $2.057 million, or $0.01 per share, in the same period last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Legend Biotech Corporation (spons. ADRs)mehr Nachrichten
|
11.11.25 |
Ausblick: Legend Biotech stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
|
10.08.25 |
Ausblick: Legend Biotech stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |
Analysen zu Legend Biotech Corporation (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
| Legend Biotech Corporation (spons. ADRs) | 25,20 | -3,08% |
|